[HTML][HTML] Risk factors of severe COVID-19: a review of host, viral and environmental factors

L Zsichla, V Müller - Viruses, 2023 - mdpi.com
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

[HTML][HTML] Omicron variant of SARS-CoV-2: An Indian perspective of vaccination and management

VP Chavda, P Balar, D Vaghela, HK Solanki… - Vaccines, 2023 - mdpi.com
Omicron variants have highly influenced the entire globe. It has a high rate of
transmissibility, which makes its management tedious. There are various subtypes of …

Vaccination, immunity, and the changing impact of COVID-19 on infant health

F Torche, J Nobles - … of the National Academy of Sciences, 2023 - National Acad Sciences
In utero exposure to COVID-19 infection may lead to large intergenerational health effects.
The impact of infection exposure has likely evolved since the onset of the pandemic as new …

Comparison of symptoms associated with SARS-CoV-2 variants among children in Canada

MW Sumner, J Xie, R Zemek, K Winston… - JAMA Network …, 2023 - jamanetwork.com
Importance Clinical manifestations of SARS-CoV-2 variants have not been systematically
compared in children. Objective To compare symptoms, emergency department (ED) chest …

Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with covid-19—vision network, 10 States, June …

EP Griggs, PK Mitchell, V Lazariu… - Clinical Infectious …, 2024 - academic.oup.com
Background The epidemiology of coronavirus disease 2019 (COVID-19) continues to
develop with emerging variants, expanding population-level immunity, and advances in …

[HTML][HTML] The evolution of COVID-19: omicron and subvariants

MM Hammer - Radiology, 2023 - pubs.rsna.org
In this issue of Radiology, Lee et al (2) compared clinical and imaging outcomes of patients
infected with subvariants of Omicron, the older BA. 1/BA. 2 (n= 1269) versus newer BA. 5 (n …

[HTML][HTML] Clinical outcomes of SARS-CoV-2 breakthrough infections in liver transplant recipients during the omicron wave

A Herting, J Jahnke-Triankowski, A Harberts… - Viruses, 2023 - mdpi.com
At the start of the pandemic, liver transplant recipients (LTR) were at high risk of developing
severe COVID-19. Here, the outcomes of breakthrough infections in fully vaccinated LTR (n …

[HTML][HTML] Effectiveness of inactivated COVID-19 vaccines against delta-variant COVID-19: evidence from an outbreak in inner Mongolia autonomous region, China

C Ma, C Huang, W Wang, Y Song, X Jiang, X Tian… - Vaccines, 2023 - mdpi.com
Phase 3 clinical trials and real-world effectiveness studies showed that China's two main
inactivated COVID-19 vaccines are very effective against serious illness. In November 2021 …

Prevalence of pneumonia among patients who died with COVID-19 infection in ancestral versus omicron variant eras

MM Hammer, AD Sodickson, AD Marshall, JS Faust - Academic Radiology, 2024 - Elsevier
Rationale and Objectives The Omicron variant of COVID-19 is less severe than the ancestral
strain, leading to the potential for deaths in patients infected with the virus but who die of …

Real-world effectiveness of primary series and booster doses of inactivated coronavirus disease 2019 vaccine against Omicron BA. 2 variant infection in China: a …

L Tang, FZ Wang, LE Rodewald… - The Journal of …, 2023 - academic.oup.com
Background China has been using inactivated coronavirus disease 2019 (COVID-19)
vaccines as primary series and booster doses to protect the population from severe to fatal …